[SLN] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
30-Mar-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -48.76%
YoY- -16.52%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 573 0 0 8 0 0 4 128.57%
PBT -6,665 -4,799 -4,894 -3,328 -2,771 -2,071 -2,812 15.45%
Tax 1,150 694 550 570 405 0 0 -
NP -5,515 -4,105 -4,344 -2,758 -2,367 -2,071 -2,812 11.86%
Tax Rate - - - - - - - -
Total Cost 6,088 4,105 4,344 2,766 2,367 2,071 2,816 13.69%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -962.39 0.00 0.00 -34,475.00 0.00 0.00 -80,342.86 -52.13%
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -0.21 -0.17 -0.19 -0.12 -0.10 -0.11 -0.17 3.58%
EPS Diluted -0.21 -0.17 -0.19 -0.12 -0.10 -0.11 -0.17 3.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.